ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $18,588,000 | +1.4% | 200,000 | -25.6% | 0.21% | +0.9% |
| Q2 2021 | $18,323,000 | +57.1% | 268,661 | +59.8% | 0.21% | +40.4% |
| Q1 2021 | $11,663,000 | -54.5% | 168,086 | -49.7% | 0.15% | -58.3% |
| Q4 2020 | $25,658,000 | +20.4% | 333,960 | +17.2% | 0.36% | +11.7% |
| Q3 2020 | $21,313,000 | -27.1% | 284,967 | -38.6% | 0.32% | -26.9% |
| Q2 2020 | $29,217,000 | -14.5% | 464,124 | -43.0% | 0.44% | -34.9% |
| Q1 2020 | $34,188,000 | -1.5% | 814,006 | +6.5% | 0.68% | +48.7% |
| Q4 2019 | $34,718,000 | +20.1% | 764,376 | +21.0% | 0.46% | +9.6% |
| Q3 2019 | $28,905,000 | -2.9% | 631,533 | +24.3% | 0.42% | +8.9% |
| Q2 2019 | $29,783,000 | -8.0% | 507,986 | -29.6% | 0.38% | -10.3% |
| Q1 2019 | $32,357,000 | +5.0% | 721,765 | -8.8% | 0.43% | -4.7% |
| Q4 2018 | $30,821,000 | -38.6% | 791,298 | -27.5% | 0.45% | -18.4% |
| Q3 2018 | $50,202,000 | -5.0% | 1,090,871 | -10.0% | 0.55% | +16.0% |
| Q2 2018 | $52,834,000 | +95.6% | 1,211,800 | +77.2% | 0.47% | +111.6% |
| Q1 2018 | $27,016,000 | +47.8% | 683,937 | +27.1% | 0.22% | +54.5% |
| Q4 2017 | $18,284,000 | – | 538,248 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |